[1]
J. Darmoń, “From GLP-1 Agonism to Triple-Receptor Therapy. Narrative Review of Semaglutide, Tirzepatide, and Retatrutide in Obesity Management”., Qual Sport, vol. 54, p. 70772, Apr. 2026.